{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fiambio.simplecast.com%2Fepisodes%2Finvestment-climate-for-biotech-uPpTjX0c","width":444,"version":"1.0","type":"rich","title":"Investors Become Goldilocks in a Bear Market","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9b3967de-d938-42f2-b54e-99b29c007c9b/edf95499-0c7d-4519-8809-c86b3b8795c1/bio-podcast-logo-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f3d27f4b-3c6e-41b0-894c-034224cff911\" height=\"200\" width=\"100%\" title=\"Investors Become Goldilocks in a Bear Market\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market."}